Skip to main content
Springer logoLink to Springer
. 2025 Jul 18;18(3):877–885. doi: 10.1007/s12194-025-00942-x

Linear energy transfer correction using Al₂O₃:Cr thermoluminescent and radiophotoluminescence glass dosimeters for therapeutic proton dosimetry

Weishan Chang 1,✉, Hina Suzuki 1, Kenji Hotta 2, Puspen Chakraborty 1, Yusuke Koba 3, Nozomi Ohba 4, Kiyomitsu Shinsho 1
PMCID: PMC12339583  PMID: 40681943

Abstract

Solid-state luminescence dosimeters face challenge in achieving accurate dosimetry in proton therapy owing to the linear energy transfer (LET)-dependent response. In this study, we proposed a two-dosimeter-based methodology to improve the accuracy of proton dosimetry by correcting the LET-dependent response of a radiophotoluminescence glass dosimeter (RPLD) and an Al2O3:Cr-based ceramic-type thermoluminescence dosimeter (TLD) for postal dosimetry. The LET dependent response for the RPLD and Al2O3:Cr TLD was investigated using an unmodulated 235 MeV proton beam delivered by a passive scattering system. Both dosimeters were individually calibrated in terms of the absorbed dose to water using a 6 MV X-ray beam. The luminescence efficiency ratio between the RPLD and Al2O3:Cr TLD (ηRPLD,Al2O3:Cr) was used as an index to determine the LET dependence correction factor for the RPLD and Al2O3:Cr TLD (kLETRPLD and kLETAl2O3:Cr). Modulated proton beams with different spread-out Bragg peak (SOBP) widths were used to evaluate the feasibility of the proposed two-dosimeter methodology. ηRPLD,Al2O3:Cr decreased with increasing LET. kLETRPLD and kLETAl2O3:Cr were fitted using exponential curves. Proton dosimetry based on the proposed methodology underestimated the absorbed dose to water by an averages of 1.88% and 3.21% for RPLD and Al2O3:Cr TLD, respectively. This demonstrated the feasibility of the proposed methodology. Although the method shows promise for LET correction, the uncertainties in the LET-dependent correction factors, namely 2.39% for the RPLD and 5.84% for the Al₂O₃:Cr TLD, indicate the need for further refinement.

Keywords: Proton therapy, Audit dosimetry, TLD, RPLD, LET dependence, Luminescence

Introduction

The energy transferred to the tissue by protons is inversely proportional to their velocity, resulting in maximum dose deposition at a certain depth in the tissue, known as the Bragg peak [1]. This property is favorable when considering the trade-off between administering the prescribed target dose and the dose to the surrounding normal tissue in radiotherapy [2]. Nevertheless, accurate dosimetry remains a critical challenge owing to variations in the linear energy transfer (LET) along the proton beam path. LET-dependent effects have been reported in many commercially available solid-state luminescence dosimeters (SSLDs) such as thermoluminescence dosimeters (TLDs) and radiophotoluminescence glass dosimeters (RPLDs). These SSLDs are widely used for in vivo dosimetry and postal dosimetry programs for interinstitutional dose intercomparisons [3–6].

A commercially used RPLD glass dosimeter of the GD-300 series (Asahi Techno, Japan), has been reported to exhibit an under-response of approximately 45% at an LET of 9.5 keV µm−1 [7–10]. In radiotherapy, luminescence efficiency (η) for SSLD is defined as the dose ratio between using SSLD and ionization chamber (IC). Chang et al. attempted to address the LET-dependent response issue by proposing a residual range (Rres)-based method to correct the stopping power and the LET dependent effect of the η on the RPLD (ηRPLD) [8]. Although the Rres-based correction method exhibits limitations in the high-LET region, it is useful in the plateau region. Yasui et al. proposed an alternative correction method based on the calculated LET [9]. The LET-based correction method improved the accuracy of RPLD measurements to within 5% of the corresponding dose by an IC. However, its practical application is limited as it requires detailed nozzle information, which is often unavailable.

A Cr-doped Al2O3-based ceramic TLD (Al2O3:Cr TLD, A10, Ceramic Mfg. Co) was proposed for application as a postal dose audit dosimeter and quality assurance tool in photon radiotherapy owing to its high solidity and durability [11, 12]. Koba et al. investigated the LET dependence of η on Al2O3:Cr TLD (ηAl2O3:Cr) using different species of charged particles [13]. They found that, in contrast to ηRPLD, which decreases with increasing LET, ηAl2O3:Cr reached its maximum of 1.2 when irradiated with a 290 MeV carbon-ion (LET: 13.5 keV µm−1) and then decreased to 0.6 when the LET was 200 keV µm−1.

In proton therapy, the LET values are typically around 0.5–12 keV µm−1 where ηAl2O3:Cr and ηRPLD increases and decreases with increasing LET, respectively. This suggests an increase in the difference between ηAl2O3:Cr and ηRPLD with increasing LET. By taking the ratio of ηAl2O3:Cr to ηRPLD, the denominator of dose by the IC can be eliminated and LET can be expressed as a function of the ratio between dose by the RPLD and the Al2O3:Cr TLD. Subsequently, the LET-dependent correction factors for both the RPLD and the Al2O3:Cr TLD can be obtained. This indicates the potential of the combined dosimetric approach. However, previously, only ηAl2O3:Cr at limited LET values of 0.5, 2, and 13 keV µm−1 were investigated, leaving a significant gap in fully understanding the LET dependence of ηAl2O3:Cr.

In this study, we developed a two-dosimeter-based methodology to improve the accuracy of proton dosimetry by addressing the LET-dependent response of the RPLD and the Al2O3:Cr TLD for postal dosimetry. As the ηAl2O3:Cr has not been comprehensively investigated in previous studies, we experimentally investigated their LET-dependent response using an unmodulated 235 MeV proton beam that was delivered by a passive beam delivery system. The proposed methodology was the experimentally validated using a modulated proton beam with different spread-out Bragg peak (SOBP) widths.

Materials and methods

Dose determination

The absorbed dose to water (Dw) at beam quality Q using an SSLD (RPLD or Al2O3:Cr TLD) was estimated using the following equation:

DwSSLD=MQSSLD×ND,wSSLD×kQ,Q0SSLD×kLETSSLD, 1

where MQSSLD denotes the reading (rdg) of the SSLD corrected for the fading effect, ND,wSSLD is the calibration coefficient (Gy rdg−1) in terms of Dw for the SSLD at the reference beam quality Q0, kQ,Q0SSLD is the beam quality correction factor for the SSLD, and kLETSSLD is an LET-dependent correction factor determined using the proposed two-dosimeter-based methodology. The fading effect correction factor f for Al2O3:Cr TLD varied with the elapsed time t [h] and was calculated as [11]

ft=-0.36169×log10t+1.7234. 2

For RPLD, f was set to 1 because all the RPLD was readout within one week after irradiation, and the fading effect was negligible (< 2% for 120 days) [5, 14].

ND,wSSLD is the ratio of Dw,Q0IC and Dw determined using an IC at the reference beam Q0, and MQ0SSLD. In this study, ND,wSSLD was determined individually for each SSLD to improve the accuracy of the measurements. Since the absorbed dose standard for proton beams has not been established, a 6 MV X-ray from LINAC (Elekta VersaHD) was used as the reference beam in this study.

kQ,Q0SSLD for RPLD was calculated using Eq. (3), as reported in the previous study [8]:

kQ,Q0RPLDRres=0.994+0.052e-0.537Rres. 3

Similarly, the beam quality correction factor for the Al2O3:Cr TLD, kQ,Q0Al2O3:Cr was derived using the stopping power ratio between Al2O3:Cr and water, based on the PSTAR program [15], as follows:

kQ,Q0Al2O3:CrRres=1.0165+0.0347e-0.522Rres. 4

LET-dependent response correction factor kLETSSLD

The following framework indicates a method for using the distinct LET-dependent response between the RPLD and Al2O3:Cr TLD for LET estimation in unknown radiation fields. After accessing the relationship between LET and η for SSLD, i.e., the ηRPLD(LET) and ηAl2O3:Cr(LET), the relationship between the ratio of ηRPLD and ηAl2O3:Cr (ηRPLD,Al2O3:Cr) and LET was also derived asηRPLD,Al2O3:Cr(LET). As ηSSLD=MQSSLD×ND,wSSLD×kQ,Q0SSLD/Dw,QIC, ηRPLD,Al2O3:Cr(LET) can be expressed as

ηRPLD,Al2O3:Cr(LET)=MQRPLD×ND,wRPLD×kQ,Q0RPLD/Dw,QICMQAl2O3:Cr×ND,wAl2O3:Cr×kQ,Q0Al2O3:Cr/Dw,QIC 5

The LET value for a given measurement was determined by inverting the function. Given the kLETSSLD is determined as the reciprocal of the ηSSLD, it can be expressed as:

kLETSSLD=1/ηRPLD,Al2O3:Cr(LET) 6

Dosimetry systems

RPLD dosimetry system

In this study, the RPLD dosimetry system pertaining to GD-302M (Asahi Techno Glass) and an automatic reader pertaining to FGD-1000 (Asahi Techno Glass) were used. The GD-302M is a cylinder with a diameter and height of 1.5 mm and 12 mm, respectively. The annealing condition and readout procedures were identical to those used in our previous study [8]. To improve accuracy, the timeline of the readout procedure—preheating and reading within one week after preheating—was consistent for each experiment in the present study.

Al2O3:Cr TLD dosimetry system

The weight composition of the Al2O3:Cr TLD (A10, Chiba Ceramic Mfg. Co) is 99.5 wt% Al2O3 and 0.05 wt% Cr2O3. The dimensions of the Al2O3:Cr TLD used in this study was 10 mm × 10 mm × 0.7 mm [13]. The Al2O3:Cr TLDs were readout using an in-house developed glow curve readout system that contained a photon-counting unit (H11890-110, HAMAMATSU) with a collective lens, and programmable heat controller (SCRSHQA, SAKA-GUCHI). The detailed scheme of this readout system can be found at previous study [16]. Figure 1 shows the glow curve for Al2O3:Cr TLD that was heated from room temperature to 400 °C at a heating rate of 0.2 °C s−1. In this study, the TL between 40 °C and 400 °C was recorded to plot the glow curve. The main glow peak was observed at 310 °C, and the cumulated TL intensity between 305 °C and 315 °C was used to determine the absorbed dose rather than the total integral TL. This is because the total integral TL may contain the thermal radiation from the brass heating plate used in the TLD readout system. During heating, the brass plate emits infrared radiation that can be detected by the photomultiplier tube and consequently overestimate the TL signal. Al2O3:Cr TLDs were enveloped in a dark box immediately after irradiation to prevent light-induced decay and all TLDs were maintained at room temperature before readout.

Fig. 1.

Fig. 1

Glow curve for Al2O3:Cr TLD

Experiment

LET dependence of luminescence efficiency

A non-modulated 235 MeV proton beams from the National Cancer Center EAST Hospital (NCCEH) was used to access the LET dependent luminescence efficiency of RPLD and Al2O3:Cr TLD. The Beam delivery system in the NCCEH was implemented with a double-scattering method to produce a uniform lateral dose distribution [17]. A water equivalent solid phantom, tough water WD (Kyoto Kagaku Co) was customized simultaneously hold the RPLD and Al2O3:Cr TLD for irradiation (Fig. 2). The geometric centers of the RPLD and front surfaces of the Al2O3:Cr TLD were set at the isocenter. Since the RPLD has a small diameter of 1.2 mm and an active volume diameter of 1 mm, aligning based on water-equivalent thickness would require impractically precise adjustments. Therefore, alignment was performed based on physical depth rather than water-equivalent thickness [18]. 1 Gy was delivered to the RPLDs and the Al2O3:Cr TLDs with 10 cm × 10 cm field. Four RPLDs and Al2O3:Cr TLDs were used for one irradiation condition.

Fig. 2.

Fig. 2

Customized tough water WD phantom used in the experiment: a phantom placed above the detectors, showing embedded positions for RPLDs only because the active region of the RPLD is located at its center; b phantom placed below the detectors, showing the embedded positions of both RPLDs and Al₂O₃:Cr TLDs

The LET was varied using slabs made of poly(methyl methacrylate) (PMMA). In this study, the dose-averaged LET, which is a better parameter for estimating the relative efficiency of a detector in a proton beam when performing depth dose measurements [19], was calculated using the Monte Carlo simulation code PHITS (Particle and Heavy Ion Transport code system), version 3.26 [20]. Simulations were performed by assuming a Gaussian shape for the energy spectrum with mean energy of 226 MeV and the full width at half maximum of the Gaussian distribution was set as 0.6 MeV. A total of 2.5 × 108 initial proton particles were set for simulation and transport parameter such as the energy and angular straggling for protons followed the recommendation as shown in Table 1. All simulations were conducted on 16 cores of the Intel Xeon Gold running at 2.9 GHz and the depth dose distribution was calculated with statistic uncertainties within 0.2%. Figure  3 shows the relationship between measurements depths, LET, and the dose distribution by measurement and MC calculation. The LET corresponding to the thickness of PMMA are listed in Table 2.

Table 1.

Simulation related parameters used in this study

Parameter Value Explanation
nedisp 1 Energy straggling option for charged particle and nuclei; 1 is set to refer Landau Vavilov energy straggling
nspred 2 Options for Coulomb diffusion (angle straggling); 2 is set to have Coulomb diffusion by the Lynch’s formula based on the Moliere theory
ascat1 13.6 Parameter A in the Lynch’s formula for nspred = 2
ascat2 0.038 Parameter B in the Lynch’s formula for nspred = 2
Negs 1 Parameter related to electron, positron, and photon transport; 1 is to transport electrons, positrons, and photons based on the EGS5 algorithm
Epstfl 1 Parameter related to density correction factors; 1 is set to use ICRU90 density correction factors
Fig. 3.

Fig. 3

The relationship between measurement depths, LET, and dose distributions by measurement and MC calculation

Table 2.

PMMA thickness vs. LET in an unmodulated 235 MeV proton beam

PMMA thickness [mm] 95 105 154 206 217 234 238 241 243 244
LET [keV µm−1] 0.89 1.05 1.19 1.43 1.55 1.87 2.01 2.15 2.27 2.35
PMMA thickness [mm] 245 246 247 248 249 251 252 253 254 255
LET [keV µm−1] 2.43 2.52 2.63 2.76 2.91 3.28 3.49 3.67 3.8 3.93

Verification experiment

Modulated (width of SOBP = 4, and 10 cm) 235 MeV proton beams from the NCCEH were used to validate the feasibility of the developed two-dosimeter-based methodology. Doses in the plateau region (5 cm) and SOBP region (center of the SOBP, 1 cm proximal and 1 cm distal to the center of SOBP) were measured for comparison. The irradiation dose was 1 Gy determined using an Advanced Markus IC (Type 34045 PTW, Germany) at each depth.

Results

LET dependence

Figure 4 shows the luminescence efficiencies of the RPLD ηRPLD and Al2O3:Cr TLD ηAl2O3:Cr as functions of LET. ηRPLD decreased with increasing LET, whereas ηAl2O3:Cr increased with increasing LET. The error bars represent the standard deviation of the measured results. The standard deviation of the Al2O3:Cr TLD was relatively larger than RPLD, with the maximum standard deviation reaching 8.8%. Nevertheless, the average coefficients of variation for Al2O3:Cr TLD and RPLD were 4.5% and 1.7%, respectively. To clarify the relationship between ηRPLD and ηAl2O3:Cr, the dose ratio of the RPLD and Al2O3:Cr TLD ηRPLD,Al2O3:Cr are shown in Fig. 5. ηRPLD,Al2O3:Cr decreased from 0.934 to 0.465 as the LET increased to 4 keV µm−1.

Fig. 4.

Fig. 4

ηRPLD and ηAl2O3:Cr as functions of LET

Fig. 5.

Fig. 5

Relationship between ηRPLD,Al2O3:Cr and LET

LET can be eliminated by combining Figs. 4 and 5. The relationship between the η and the ηRPLD,Al2O3:Cr was obtained. Consequently, the LET correction factor, the reciprocal of the luminescence efficiency, for the RPLD (kLETRPLD) and the Al2O3:Cr TLD (kLETAl2O3:Cr) can be expressed by the equations shown in Fig. 6.

Fig. 6.

Fig. 6

ηRPLD,Al2O3:Cr as a function of LET-dependent correction factor for the RPLD (kLETRPLD) and the Al2O3:Cr TLD (kLETAl2O3:Cr), respectively

SOBP beam

Figure 7 shows Dw obtained using RPLD and Al2O3:Cr TLD according to Eq. (1) in the modulated (SOBP = 4, and 10 cm) proton beams. The gray-painted area indicates the criteria for postal dosimetry audit of ± 5% [21]. The error bars represent the standard deviation by the measurement of four SSLDs. Mean of the coefficient of the deviation for RPLD and Al2O3:Cr TLD were 0.87% and 3.74%, respectively. To correct the LET-dependent response, the correction factors shown in Fig. 6 were applied to correct the LET-dependent response. After LET dependence correction, the dose differences between DwRPLD and DwIC were between − 3.98% and 1.59% and those between DwAl2O3:Cr and DwIC were between − 5.11% and − 0.39%.

Fig. 7.

Fig. 7

Dw obtained with RPLD and Al2O3:Cr TLD at different depths in the modulated (SOBP = 4, 10 cm) proton beams. Both dosimeters were set at the same WEL in the experiments. The artificial shifting of data points ensures clear visualization of overlapping measurements

Discussion

The LET-dependent efficiencies of the RPLD and Al2O3:Cr TLD were investigated in detail using an unmodulated 235 MeV proton beam and the feasibility of the two-dosimeter-methodology was validated using the modulated (SOBP = 4, and 10 cm) proton beams. Meanwhile, Dw estimated using RPLD and Al2O3:Cr TLD showed dose differences with averages of 1.77% and 2.35%, respectively.

To further analyze the reason for the underestimation of Dw using SSLDs with the proposed method, we re-plotted the LET as a function of ηRPLD,Al2O3:Cr (Fig. 8) and estimated the LETs from ηRPLD,Al2O3:Cr. The ηRPLD,Al2O3:Cr and the LET values at each measured depth are listed in Table 3. For both SOBP beams, the estimated LETs in the plateau region were smaller than those in the SOBP region. According to the previous study [22], the average LET is between ~ 2.0 keV μm−1 and ~ 3.0 keV μm−1 (decreasing with the depth position of the SOBP center) in the SOBP center for a 10 cm SOBP beam which was consistent with our results. Moreover, in the SOBP region, the estimated LETs for the 10 cm SOBP were all smaller than that for the 4 cm SOBP which is reasonable as the SOBP center for 4 cm SOBP was closer to the distal fall-off of the SOBP. Though this comparison alone does not constitute a full validation. In this study, independent Monte Carlo simulations for LET verification were not performed due to limited geometry information for the ridge filter used in the beam delivery system, and detailed published LET profiles matching our beam conditions are limited.

Fig. 8.

Fig. 8

ηRPLD,Al2O3:Cr as a function of LET

Table 3.

LET estimated using ηRPLD,Al2O3:Cr

Location Plateau 1 cm proximal to the SOBP center SOBP center 1 cm distal to the SOBP center
4 cm SOBP ηRPLD,Al2O3:Cr 0.891 0.746 0.695 0.682
LET [keV µm−1] 1.335 2.476 2.797 2.873
10 cm SOBP ηRPLD,Al2O3:Cr 0.876 0.785 0.768 0.762
LET [keV µm−1] 1.473 2.209 2.331 2.371

The uncertainty in the proposed methodology, was mainly attributed to kLETRPLD and kLETAl2O3:Cr. The uncertainties for the correction factors were combined including (1) the uncertainty of the experimental ηRPLD and ηAl2O3:Cr, (2) the estimated LET, and (3) the regression curve for the kLETRPLD and the kLETAl2O3:Cr (Fig. 6). The uncertainties of the experimental ηRPLD and ηAl2O3:Cr were the combined uncertainty contributed by the type A uncertainty of MSSLD and DwIC which were estimated as 0.99% and 2.3% for ηRPLD and ηAl2O3:Cr, respectively. The uncertainty of the estimated LET was 1.35% from a previous study [8]. The uncertainty from the regression curves for the kLETRPLD and the kLETAl2O3:Cr was classified as type B with a rectangular distribution following the approach by Mizuno et al. [23]. The values were estimated to be 1.7% and 5.2%, respectively, based on the observed maximum deviation between the experimental points and the fitting curve. The combined uncertainties for the correction factors of the RPLD and the Al2O3:Cr TLD were 2.39% and 5.84%, respectively. The uncertainty of our proposed methodology was relatively large for the postal dosimetry audit criteria. A major contributor to the uncertainty of the Al₂O₃:Cr TLD is from MSSLD. Previously Maruyama et al. estimated the uncertainty of the Al₂O₃:Cr TLD as 1.8% [11], which is significantly lower than the uncertainty estimated in our protocol. This discrepancy is largely attributed to differences in readout system performance. We are currently developing a new readout system aimed at improving reproducibility and reducing statistical noise. Even though the uncertainty may be relatively large, the purpose of this study was to show the protentional of the two-dosimeter LET correction methodology and highlights the potential for improvement with refined instrumentation. In addition, a slight discrepancy on the ηRPLD between this study and previous studies [8–10] should be noted. ηRPLD decrease by around 10% to 15% at LET = 1–3 keV µm−1 in previous studies [8–10], while it was found a gradual decrease in ηRPLD in this LET region. In Nagata et al., the overall variation in ηRPLD was within 1% in LET range of 1.4–2.8 keV µm−1 [10]. Moreover, in the study by Chang et al., ηRPLD was reported to decrease significantly from approximately 0.88 to 0.70 as LET increased from 1 to 3 keV µm−1 indicating a sharper decline compared with our results. Nevertheless, at higher LET values around 4 keV µm−1, our findings are consistent with Chang et al.’s results, where ηRPLD decreased to approximately 0.6. Possible reasons for the discrepancies include the differences in beam conditions, and readout procedures [8]. As we followed Chang et al.’s readout procedure that read out within 1 week after irradiation following a consistent preheating protocol, and individually calibrated using a 6-MV photon beam, maybe the difference results by the RPLD batch properties.

Another limitation of this study is that the validation experiment was only performed on a passive proton beam delivery system. Since the scanning beam delivery systems are being widely adopted, the feasibility of the proposed methodology for scanning proton beams needs to be investigated. Despite these limitations, the concept of combining two detectors with complementary LET-dependent responses presents a significant advantage—to estimate LET and derive LET-dependent correction factors directly, without relying on external beam quality indices such as the residual range or pre-calculated LET. Although the accuracy of the present method remains limited, the proposed two-dosimeter approach demonstrates strong potential to simplify LET correction procedures and enhance the practicality of proton dosimetry.

Conclusion

In this study, we developed a two-dosimeter methodology for deriving the LET dependence correction factor and validated it using therapeutic SOBP proton beams. Proton dosimetry based on the proposed methodology underestimated the Dw by an average of 1.88% and 3.21% for the RPLD and Al2O3:Cr TLD, respectively. This demonstrated the feasibility of the proposed methodology. By employing two SSLDs with opposing LET-dependent responses, the need for ionization chambers is eliminated, which is advantageous for postal dosimetry applications. Although the current uncertainty levels are relatively high, further refinement of readout systems, which is currently underway, is expected to improve the accuracy and precision. Therefore, we concluded that the two-dosimeter methodology is promising for LET correction.

Author contributions

All authors contributed significantly to the conception, design, and execution of this study.

Funding

Open access funding provided by Tokyo Metropolitan University. This work was supported by JSPS KAKENHI Grant Number 20K16745.

Data availability

The data that support the finding of this study are available from the corresponding author on reasonable request.

Declarations

Conflict of interest

The authors have no conflict of interest to disclose.

Ethical statement

This article does not contain any studies with human or animal subjects.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Newhauser WD, Zhang R. The physics of proton therapy. Phys Med Biol. 2015;60(8):R155–209. 10.1088/0031-9155/60/8/R155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mohan R. A review of proton therapy – current status and future directions. Precis Radiat Oncol. 2022;6(2):164–76. 10.1002/pro6.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Shehzadi NN, et al. Feasibility study of radiophotoluminescent glass dosimeter for in vivo dosimetry in external photon beam radiotherapy. J Korean Phys Soc. 2021;78(6):523–34. 10.1007/s40042-021-00092-4. [Google Scholar]
  • 4.Lonski P, Kron T. Impact through versatility: patterns of in vivo dosimetry utilization with TLD across a large multi-site radiotherapy department. Front Oncol. 2022;12(October):1–8. 10.3389/fonc.2022.918178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mizuno H, et al. Feasibility study of glass dosimeter postal dosimetry audit of high-energy radiotherapy photon beams. Radiother Oncol. 2008;86(2):258–63. 10.1016/j.radonc.2007.10.024. [DOI] [PubMed] [Google Scholar]
  • 6.Izewska J, et al. Testing the methodology for dosimetry audit of heterogeneity corrections and small MLC-shaped fields: results of IAEA multi-center studies. Acta Oncol (Madr). 2016;55(7):909–16. 10.3109/0284186X.2016.1139180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rah JE, et al. Feasibility study of glass dosimeter for in vivo measurement: dosimetric characterization and clinical application in proton beams. Int J Radiat Oncol Biol Phys. 2012;84(2):e251–6. 10.1016/j.ijrobp.2012.03.054. [DOI] [PubMed] [Google Scholar]
  • 8.Chang W, et al. Correction of stopping power and LET quenching for radiophotoluminescent glass dosimetry in a therapeutic proton beam. Phys Med Biol. 2017;62(23):8869–81. 10.1088/1361-6560/aa9155. [DOI] [PubMed] [Google Scholar]
  • 9.Yasui K, et al. Dosimetric response of a glass dosimeter in proton beams: LET-dependence and correction factor. Phys Medica. 2021;81(November):147–54. 10.1016/j.ejmp.2020.12.001. [DOI] [PubMed] [Google Scholar]
  • 10.Nagata J, et al. Evaluation of radiophotoluminescent glass dosimeter response for therapeutic spot scanning proton beam: suggestion of linear energy transfer-based correction. J Appl Clin Med Phys. 2021;22(8):265–72. 10.1002/acm2.13378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Maruyama D, Yanagisawa S, Koba Y, Andou T, Shinsho K. Usefulness of thermoluminescent slab dosimeter for postal dosimetry audit of external radiotherapy systems. Sensors Mater. 2020;32(4):1461–77. 10.18494/SAM.2020.2697. [Google Scholar]
  • 12.Yanagisawa S, Maruyama D, Oh R, Koba Y, Andoh T, Shinsho K. Two-dimensional thermoluminescence dosimetry using Al2O3:Cr ceramics for 4, 6, and 10 MV X-ray beams. Sensors Mater. 2020;32(4):1479–87. 10.18494/SAM.2020.2698. [Google Scholar]
  • 13.Koba Y, et al. Dose linearity and linear energy transfer dependence of Cr-doped Al2O3 ceramic thermoluminescence detector. Sensors Mater. 2018;30(7):1599. 10.18494/SAM.2018.1930. [Google Scholar]
  • 14.Rah J-E, et al. Feasibility study of glass dosimeter for postal dose intercomparison of high-energy proton therapy beams. Radiat Meas. 2013;59:66–72. 10.1016/j.radmeas.2013.10.004. [Google Scholar]
  • 15.Berger J, Zucker M. ESTAR, PSTAR, and ASTAR: computer programs for calculating stopping-power and range tables for electrons, protons, and helium ions (version 1.2.2). National Institute of Standards and Technology; 2004. http://physics.nist.gov/Star.
  • 16.Chang W, Koba Y, Fukuda S, Wakabayashi G, Saitoh H, Shinsho K. Absorbed dose estimation using LET dependence in glow curve of thermoluminescent phosphor Li3B7O12:Cu in therapeutic carbon beams. J Nucl Sci Technol. 2016. 10.1080/00223131.2016.1181010. [Google Scholar]
  • 17.Yoshihisa Takada YT. Dual-ring double scattering method for proton beam spreading. Jpn J Appl Phys. 1994;33(1R):353. 10.1143/JJAP.33.353. [Google Scholar]
  • 18.Kadoya N, et al. Dosimetric properties of radiophotoluminescent glass detector in low-energy photon beams. Med Phys. 2012;39(10):5910–6. 10.1118/1.4747261. [DOI] [PubMed] [Google Scholar]
  • 19.Greubel C, et al. Investigation of EBT2 and EBT3 films for proton dosimetry in the 4–20 MeV energy range. Radiat Environ Biophys. 2015;54:71–9. 10.1007/s00411-014-0581-2. [DOI] [PubMed] [Google Scholar]
  • 20.Sato T, et al. Recent improvements of the particle and heavy ion transport code system–PHITS version 3.33. J Nucl Sci Technol. 2024;61(1):127–35. 10.1080/00223131.2023.2275736. [Google Scholar]
  • 21.Dimitriadis A, et al. IAEA/WHO postal dosimetry audit methodology for electron beams using radio photoluminescent dosimeters. Med Phys. 2023;50(11):7214–21. 10.1002/mp.16776. [DOI] [PubMed] [Google Scholar]
  • 22.Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59(22):R419–72. 10.1088/0031-9155/59/22/R419. [DOI] [PubMed] [Google Scholar]
  • 23.Mizuno H, et al. Application of a radiophotoluminescent glass dosimeter to nonreference condition dosimetry in the postal dose audit system. Med Phys. 2014. 10.1118/1.4898596. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the finding of this study are available from the corresponding author on reasonable request.


Articles from Radiological Physics and Technology are provided here courtesy of Springer

RESOURCES